Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

The impact of gastroesophageal reflux disease symptoms in scleroderma: effects on sleep quality.

Horsley-Silva JL, Umar SB, Vela MF, Griffing WL, Parish JM, DiBaise JK, Crowell MD.

Dis Esophagus. 2019 May 1;32(5). pii: doy136. doi: 10.1093/dote/doy136.

PMID:
30715227
2.

Factors Associated With Use of Nonoral Nutrition and Hydration Support in Adult Patients With Postural Tachycardia Syndrome.

Tseng AS, Traub NA, Harris LA, Crowell MD, Hoffman-Snyder CR, Goodman BP, DiBaise JK.

JPEN J Parenter Enteral Nutr. 2018 Dec 18. doi: 10.1002/jpen.1493. [Epub ahead of print]

PMID:
30561086
3.

Weight Loss in Parkinson's Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth.

DiBaise JK, Crowell MD, Driver-Dunckley E, Mehta SH, Hoffman-Snyder C, Lin T, Adler CH.

J Parkinsons Dis. 2018;8(4):571-581. doi: 10.3233/JPD-181386.

PMID:
30149465
4.

Postural Tachycardia Syndrome (POTS) and the GI Tract: A Primer for the Gastroenterologist.

DiBaise JK, Harris LA, Goodman B.

Am J Gastroenterol. 2018 Oct;113(10):1458-1467. doi: 10.1038/s41395-018-0215-4. Epub 2018 Aug 3. Review.

PMID:
30072778
5.

Proceedings of the 2017 ASPEN Research Workshop-Gastric Bypass: Role of the Gut.

Jain AK, le Roux CW, Puri P, Tavakkoli A, Gletsu-Miller N, Laferrère B, Kellermayer R, DiBaise JK, Martindale RG, Wolfe BM.

JPEN J Parenter Enteral Nutr. 2018 Feb;42(2):279-295. doi: 10.1002/jpen.1121. Review.

6.

Small Intestinal Bacterial Overgrowth: Nutritional Implications, Diagnosis, and Management.

Adike A, DiBaise JK.

Gastroenterol Clin North Am. 2018 Mar;47(1):193-208. doi: 10.1016/j.gtc.2017.09.008. Epub 2017 Dec 7. Review.

PMID:
29413012
7.

Clinical utility of gastric emptying scintigraphy: Patient and physician perspectives.

Tseng AS, Crowell MD, DiBaise JK.

Neurogastroenterol Motil. 2018 May;30(5):e13279. doi: 10.1111/nmo.13279. Epub 2017 Dec 21.

PMID:
29266606
8.

Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia.

Lacy BE, Saito YA, Camilleri M, Bouras E, DiBaise JK, Herrick LM, Szarka LA, Tilkes K, Zinsmeister AR, Talley NJ.

Am J Gastroenterol. 2018 Feb;113(2):216-224. doi: 10.1038/ajg.2017.458. Epub 2017 Dec 19.

PMID:
29257140
9.

Managing the Adult Patient With Short Bowel Syndrome.

Parrish CR, DiBaise JK.

Gastroenterol Hepatol (N Y). 2017 Oct;13(10):600-608.

10.

Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following Total Colectomy.

Orenstein R, King K, Patron RL, DiBaise JK, Etzioni D.

Clin Infect Dis. 2018 Jan 6;66(2):299-300. doi: 10.1093/cid/cix736.

PMID:
29020255
11.

Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection.

Patron RL, Hartmann CA, Allen S, Griesbach CL, Kosiorek HE, DiBaise JK, Orenstein R.

Clin Infect Dis. 2017 Oct 1;65(7):1214-1217. doi: 10.1093/cid/cix511.

PMID:
28575220
12.

Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding.

Ilhan ZE, DiBaise JK, Isern NG, Hoyt DW, Marcus AK, Kang DW, Crowell MD, Rittmann BE, Krajmalnik-Brown R.

ISME J. 2017 Sep;11(9):2047-2058. doi: 10.1038/ismej.2017.71. Epub 2017 May 26.

13.

Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial.

Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ.

Am J Gastroenterol. 2017 Jun;112(6):903-909. doi: 10.1038/ajg.2017.52. Epub 2017 Mar 14.

PMID:
28291238
14.

A Magnetic Hitchhiker.

Adike A, Noelting J, Dibaise JK.

Am J Gastroenterol. 2017 Feb;112(2):209. doi: 10.1038/ajg.2016.474. No abstract available.

PMID:
28154387
15.

Nutrient deficiencies prior to bariatric surgery.

Roust LR, DiBaise JK.

Curr Opin Clin Nutr Metab Care. 2017 Mar;20(2):138-144. doi: 10.1097/MCO.0000000000000352. Review.

PMID:
27941357
16.

Esophageal Motor Abnormalities in Patients With Scleroderma: Heterogeneity, Risk Factors, and Effects on Quality of Life.

Crowell MD, Umar SB, Griffing WL, DiBaise JK, Lacy BE, Vela MF.

Clin Gastroenterol Hepatol. 2017 Feb;15(2):207-213.e1. doi: 10.1016/j.cgh.2016.08.034. Epub 2016 Sep 6.

PMID:
27613260
17.

ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient.

McClave SA, DiBaise JK, Mullin GE, Martindale RG.

Am J Gastroenterol. 2016 Mar;111(3):315-34; quiz 335. doi: 10.1038/ajg.2016.28. Epub 2016 Mar 8.

PMID:
26952578
18.

Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.

Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK.

Microbiome. 2016 Feb 22;4:10. doi: 10.1186/s40168-016-0158-1. No abstract available.

19.

The relationship among gastroparetic symptoms, quality of life, and gastric emptying in patients referred for gastric emptying testing.

DiBaise JK, Patel N, Noelting J, Dueck AC, Roarke M, Crowell MD.

Neurogastroenterol Motil. 2016 Feb;28(2):234-42. doi: 10.1111/nmo.12718. Epub 2015 Nov 7.

PMID:
26547484
20.

Psychological distress in Rome III functional dyspepsia patients presenting for testing of gastric emptying.

Dibaise JK, Islam RS, Dueck AC, Roarke MC, Crowell MD.

Neurogastroenterol Motil. 2016 Feb;28(2):196-205. doi: 10.1111/nmo.12709. Epub 2015 Oct 28.

PMID:
26511077
21.

Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease.

Aqel B, DiBaise JK.

Nutr Clin Pract. 2015 Dec;30(6):780-6. doi: 10.1177/0884533615605811. Epub 2015 Oct 8. Review.

PMID:
26449892
22.

The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy.

Shah SL, Lacy BE, DiBaise JK, Vela MF, Crowell MD.

Aliment Pharmacol Ther. 2015 Nov;42(9):1093-100. doi: 10.1111/apt.13394. Epub 2015 Sep 8.

23.

The Impact of Pelvic Floor and Lower Gastrointestinal Symptoms on Quality of Life in Women With Systemic Sclerosis.

Umar SB, Griffing L, Garcia H, Foxx-Orenstein AE, DiBaise JK, Crowell MD.

J Clin Gastroenterol. 2016 Jul;50(6):e55-9. doi: 10.1097/MCG.0000000000000405.

PMID:
26325189
24.

Opioid-Induced Esophageal Dysfunction (OIED) in Patients on Chronic Opioids.

Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, Lacy BE, Murray JA.

Am J Gastroenterol. 2015 Jul;110(7):979-84. doi: 10.1038/ajg.2015.154. Epub 2015 Jun 2.

PMID:
26032150
25.

Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.

Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR.

Gastroenterology. 2015 Aug;149(2):340-9.e2. doi: 10.1053/j.gastro.2015.04.020. Epub 2015 Apr 25.

26.

Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool.

Crowell MD, Umar SB, Lacy BE, Jones MP, DiBaise JK, Talley NJ.

Dig Dis Sci. 2015 Aug;60(8):2270-9. doi: 10.1007/s10620-015-3647-3. Epub 2015 Apr 5.

PMID:
25842355
27.

Gut microbial and short-chain fatty acid profiles in adults with chronic constipation before and after treatment with lubiprostone.

Kang DW, DiBaise JK, Ilhan ZE, Crowell MD, Rideout JR, Caporaso JG, Rittmann BE, Krajmalnik-Brown R.

Anaerobe. 2015 Jun;33:33-41. doi: 10.1016/j.anaerobe.2015.01.005. Epub 2015 Jan 21.

PMID:
25617726
28.

Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility.

Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK.

Microbiome. 2014 Nov 25;2:42. doi: 10.1186/2049-2618-2-42. eCollection 2014. Erratum in: Microbiome. 2016;4:10.

29.

Esophageal peristaltic defects in adults with functional dysphagia.

Ratuapli SK, Hansel SL, Umar SB, Burdick GE, Ramirez FC, Fleischer DE, Harris LA, Lacy BE, DiBaise JK, Crowell MD.

Dysphagia. 2014 Aug;29(4):519-26. doi: 10.1007/s00455-014-9540-y. Epub 2014 Jun 4.

PMID:
24894375
30.

Short bowel syndrome and small bowel transplantation.

DiBaise JK.

Curr Opin Gastroenterol. 2014 Mar;30(2):128-33. doi: 10.1097/MOG.0000000000000035. Review.

PMID:
24445328
31.

Parenteral nutrition utilization: response to drug shortages.

Guenter P, Holcombe B, Mirtallo JM, Plogsted SW, DiBaise JK; Clinical Practice and Public Policy Committees, American Society for Parenteral and Enteral Nutrition.

JPEN J Parenter Enteral Nutr. 2014 Jan;38(1):11-2. doi: 10.1177/0148607113511273. Epub 2013 Nov 13. No abstract available.

PMID:
24225263
32.

American Society for Parenteral and Enteral Nutrition research agenda.

Chan LN, Compher C, DiBaise JK, Dimaria-Ghalili RA, Guenter P, Resnick HE, Ziegler TR; Research Committee; American Society for Parenteral and Enteral Nutrition.

JPEN J Parenter Enteral Nutr. 2014 Jan;38(1):13-8. doi: 10.1177/0148607113508783. Epub 2013 Nov 4. No abstract available.

PMID:
24190899
33.

Moving fecal microbiota transplantation into the mainstream.

Orenstein R, Griesbach CL, DiBaise JK.

Nutr Clin Pract. 2013 Oct;28(5):589-98. doi: 10.1177/0884533613497516. Epub 2013 Aug 26.

PMID:
23979974
34.

Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience.

Patel NC, Griesbach CL, DiBaise JK, Orenstein R.

Mayo Clin Proc. 2013 Aug;88(8):799-805. doi: 10.1016/j.mayocp.2013.04.022.

PMID:
23910407
35.

Role of the gastroenterologist in managing obesity.

Dibaise JK, Foxx-Orenstein AE.

Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5):439-51. doi: 10.1586/17474124.2013.811061. Review.

PMID:
23899283
36.

Appendectomy is not associated with adverse outcomes in clostridium difficile infection: a population-based study.

Khanna S, Baddour LM, Dibaise JK, Pardi DS.

Am J Gastroenterol. 2013 Apr;108(4):626-7. doi: 10.1038/ajg.2012.475. No abstract available.

PMID:
23552320
37.

Nutrition assessment and management in advanced liver disease.

Johnson TM, Overgard EB, Cohen AE, DiBaise JK.

Nutr Clin Pract. 2013 Feb;28(1):15-29. doi: 10.1177/0884533612469027. Review.

PMID:
23319353
38.

Quick fix or long-term cure? Pros and cons of bariatric surgery.

Madura JA 2nd, Dibaise JK.

F1000 Med Rep. 2012;4:19. doi: 10.3410/M4-19. Epub 2012 Oct 2.

39.

Review article: current treatment options and management of functional dyspepsia.

Lacy BE, Talley NJ, Locke GR 3rd, Bouras EP, DiBaise JK, El-Serag HB, Abraham BP, Howden CW, Moayyedi P, Prather C.

Aliment Pharmacol Ther. 2012 Jul;36(1):3-15. doi: 10.1111/j.1365-2036.2012.05128.x. Epub 2012 May 16. Review.

40.

Effects of gut microbes on nutrient absorption and energy regulation.

Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK.

Nutr Clin Pract. 2012 Apr;27(2):201-14. doi: 10.1177/0884533611436116. Epub 2012 Feb 24. Review.

41.

Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics.

Talley NJ, Locke GR 3rd, Herrick LM, Silvernail VM, Prather CM, Lacy BE, DiBaise JK, Howden CW, Brenner DM, Bouras EP, El-Serag HB, Abraham BP, Moayyedi P, Zinsmeister AR.

Contemp Clin Trials. 2012 May;33(3):523-33. doi: 10.1016/j.cct.2012.02.002. Epub 2012 Feb 10.

42.

Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth.

Ratuapli SK, Ellington TG, O'Neill MT, Umar SB, Harris LA, Foxx-Orenstein AE, Burdick GE, Dibaise JK, Lacy BE, Crowell MD.

Am J Gastroenterol. 2012 May;107(5):730-5. doi: 10.1038/ajg.2012.4. Epub 2012 Feb 14.

PMID:
22334250
43.

Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel.

DiBaise JK, Richmond BK, Ziessman HA, Everson GT, Fanelli RD, Maurer AH, Ouyang A, Shamamian P, Simons RJ, Wall LA, Weida TJ, Tulchinsky M.

Clin Nucl Med. 2012 Jan;37(1):63-70. doi: 10.1097/RLU.0b013e31823e26bb.

PMID:
22157031
44.

Paraneoplastic gastrointestinal dysmotility: when to consider and how to diagnose.

DiBaise JK.

Gastroenterol Clin North Am. 2011 Dec;40(4):777-86. doi: 10.1016/j.gtc.2011.09.004. Review.

PMID:
22100117
45.

Interrater and intrarater agreement of the chicago classification of achalasia subtypes using high-resolution esophageal manometry.

Hernandez JC, Ratuapli SK, Burdick GE, Dibaise JK, Crowell MD.

Am J Gastroenterol. 2012 Feb;107(2):207-14. doi: 10.1038/ajg.2011.353. Epub 2011 Oct 18.

PMID:
22008895
46.

Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.

Frazier TH, DiBaise JK, McClain CJ.

JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Epub 2011 Aug 1. Review.

PMID:
21807932
47.

Nutrition and metabolic complications after bariatric surgery and their treatment.

Fujioka K, DiBaise JK, Martindale RG.

JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):52S-9S. doi: 10.1177/0148607111413600. Epub 2011 Jul 28.

PMID:
21799192
48.

Symptoms, stones, and surgery: predicting pain relief after cholecystectomy for gallstones.

Dibaise JK.

Clin Gastroenterol Hepatol. 2011 Oct;9(10):818-20. doi: 10.1016/j.cgh.2011.05.024. Epub 2011 Jun 6. No abstract available.

PMID:
21683164
49.

Low-residue diet in diverticular disease: putting an end to a myth.

Tarleton S, DiBaise JK.

Nutr Clin Pract. 2011 Apr;26(2):137-42. doi: 10.1177/0884533611399774. Review.

PMID:
21447765
50.

Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel.

DiBaise JK, Richmond BK, Ziessman HH, Everson GT, Fanelli RD, Maurer A, Ouyang A, Shamamian P, Simons RJ, Wall LA, Weida TJ, Tulchinsky M.

Clin Gastroenterol Hepatol. 2011 May;9(5):376-84. doi: 10.1016/j.cgh.2011.02.013. Epub 2011 Feb 17. Review.

PMID:
21334459

Supplemental Content

Loading ...
Support Center